home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Pharma R&D Asia Congress

 
  September 04, 2014  
     
 
Oxford Global, TBC, Shanghai, China
27-28 January 2015


The 4th Annual Clinical Development and Trials Asia Congress is to be held on 27th & 28th January 2015, Shanghai, China. Attended by over 170 industry leaders in Clinical Development & Clinical Trials Development in Asia, the Congress will offer invaluable insights on successful strategies and technologies in enabling clinical development, clinical outsourcing strategies and clinical trial management.

 

 

 

To download the conference agenda, please visit http://www.pharmaworldasia-congress.com/download-agenda-marketing/

 
 
Organized by: Oxford Global
Invited Speakers:
  • Jun Bao
    Senior Vice President and Chief Business Officer, Shenogen Pharma Group
  • Victoria Elegant
    Vice President of Medical & Regulatory Affairs, Baxter, China
  • Frank Grams
    VP, Head Alliance Management & Transactions, Sanofi R&D
  • Yariv Hefez
    Vice President Business Development, Portfolio Management, Strategy and Partnering, Biosimilars Unit, Merck
  • Yong-jiang Hei
    Executive Medical Director, Amgen China
  • Oliver Kong
    Senior Director, Clinical Development Oncology, Celgene Corporation
  • Zhengqing Li
    VP and Head of China Development, MSD
  • Zheng Li
    General Manager, Head of Research China, Lundbeck
  • Jian Li
    Director, Partnering and External Innovation - Asia Pacific, Sanofi R&D
  • Dan Paulson
    Vice President, Global Clinical Development, Group Head, Cardiovascular Risk Management and Women’s HealthCare, Bayer HealthCare Company Limited Global R&D Centre
  • Akhilesh Sharma
    Senior Vice President & Global Head Global Medical Affairs, Dr. Reddy's Laboratories India
  • Jagdev Sidhu
    Senior Director Clinical Pharmacology & Pharmacometrics,CSL Limited
  • Cezary Statuch
    Vice President of R&D, Bristol-Myers Squibb, China
  • Dejun Tang
    Site Head, Biometrics & Statistical Sciences and Methodology. Novartis, China
  • David Tattersall
    Director, Neurodegeneration Parkinson's Disease Group, GSK R&D China Shanghai
  • Patrecia Vaone
    Senior Director, Development Operations, Takeda Development Center Asia and Takeda Shanghai Development Center
  • Wei Wang
    Associate Director, Safety Surveillance and Risk Management, Pfizer, China
  • Jingsong Wang
    Head of China R&D, Head of Translational Medicine, Asia Pacific Sanofi
  • Hank Wu
    Director of IT, Discovery Sciences, Biogen Idec
  • Mingde Xia
    Senior Director, Johnson & Johnson Innovation Center, USA
 
Deadline for Abstracts: N/A
 
Registration: For further information and to enquire about prices and available discounts, please contact Steph Punfield on s.punfield@oxfordglobal.co.uk or call +44 (0)1865 248455.
E-mail: s.punfield@oxfordglobal.co.uk
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.